Republic of Korea is a leader in regenerative cardiology because of direct delivery methods. Clinics use arterial injections to send stem cells directly to the heart. This approach bypasses the lungs and liver common with standard IV drips. Use of a patient's own cells simplifies regulatory access to treatment.
- Arterial delivery. Clinics like RE:YOUTH deliver stem cells via coronary arteries to reach damaged heart tissue.
- Treatment speed. Approved clinics offer autologous treatments without the long waitlists found in Western nations.
- Quality standards. KOIHA accreditation ensures that Korean medical centers meet global safety and quality benchmarks.
- Focused expertise. Specialized institutions like RE:YOUTH treat 1,000+ patients annually using dedicated regenerative protocols.
Bookimed Expert Insight: Korea's infrastructure for heart therapy is highly concentrated. Centers like RE:YOUTH specifically specialize in intra-arterial delivery, a technique not widely available elsewhere. This method ensures stem cells reach the target organ in higher concentrations. Therapy costs typically range from $29,300 to $29,300.
What patients say: Patients note the high cost of treatment and mention Korea's strong reputation for biotechnology. Many observe that while information is common for orthopedic cases, heart treatment feels specialized. They appreciate the private and coordinated care provided by dedicated international patient teams in Korea.